Clinical Scorecard: Newborn Vitamin K Refusal Trends

At a Glance

Key Highlights

• Refusal rates for vitamin K injections in the US remain below 1% but are increasing in some regions.
• Infants who do not receive vitamin K are 81 times more likely to develop late vitamin K deficiency bleeding.
• 63% of vitamin K deficiency bleeding cases present with intracranial hemorrhage.
• Parents who refuse vitamin K are significantly more likely to decline other vaccinations.
• Common reasons for refusal include concerns about injection pain and misinformation.

Guideline-Based Recommendations

Diagnosis

• Monitor for signs of vitamin K deficiency bleeding in infants who did not receive prophylaxis.

Management

• Administer intramuscular vitamin K prophylaxis at birth to prevent deficiency bleeding.

Monitoring & Follow-up

• Follow up on infants who refuse vitamin K for potential neurodevelopmental issues.

Risks

• Increased risk of intracranial hemorrhage and long-term neurologic disabilities in infants who do not receive vitamin K.

Patient & Prescribing Data

Newborns, particularly those born at home or under midwife care.

Vitamin K at birth is safe and effective in preventing serious complications.

Clinical Best Practices

• Provide prenatal counseling to parents about the importance of vitamin K prophylaxis.
• Address parental concerns regarding vitamin K injections with evidence-based information.
• Encourage vaccination and preventive care alongside vitamin K administration.

References

• American Academy of Neurology Abstract